Illinois Tool Works Inc
—- Market cap
- —
- Debt
- +$8.97B
- Cash
- −$851.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ITW stock price vs ILMN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ILMN's multiple
Needs ILMN P/E.
Implied fair value · at ITW's multiple
Needs ITW P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ILLINOIS TOOL WORKS INC · implied price per share
Bear
$71.88
Base
$86.99
Bull
$109.51
Illumina, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
3M Company
ITW vs MMM
HONEYWELL INTERNATIONAL INC
ITW vs HON
General Electric Company
ITW vs GE
Parker-Hannifin Corp
ITW vs PH
THERMO FISHER SCIENTIFIC INC.
ITW vs TMO
AGILENT TECHNOLOGIES, INC.
ITW vs A
DANAHER CORP /DE/
ITW vs DHR
BIO-RAD LABORATORIES, INC.
ITW vs BIO
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
ITW vs PACB
Natera, Inc.
ITW vs NTRA
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ITW can sustain its higher operating margin and modest growth while keeping leverage under control, then the current valuation gap supports owning ITW because it trades below ILMN on every listed multiple despite stronger operating efficiency.
ITW trades at lower multiples than ILMN across P/E, P/S, EV/EBITDA, and EV/Revenue, while the implied price suggests 33.1% upside to $363.17 versus a current price of $272.76. However, the broader range context shows ITW already sits below ILMN-implied range midpoint but above the historical band midpoint, which tempers the case for a strong rerating.
Supporting Metrics